5 results
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Management of Diabetes ... FDA recommends, ... ADA/KDIGO Consensus ... #Diabetes #CKD # ... ADA #KDIGO #eGFR
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Inhibitors) - FDA ... Approved Indications ... Cymbalta) - GAD, MDD, Diabetic ... #Indications #Pharmacology ... #Psychiatry #FDA
Ketosis Disorders
Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
Ketone bodies are ... of fatty acid (FA ... ketoacidosis (AKA ... • Diabetic ketoacidosis ... #differential #diagnosis
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
and Management Summary ... sedimentation rate, insulin ... leukocytosis, psychiatric ... carbohydrate metabolism (insulin ... apparent type 2 diabetes
Intranasal Glucagon (Baqsimi)

The FDA has approved the first intranasal glucagon product! It's branded under the name
Baqsimi) The FDA ... has approved the ... older who has diabetes ... when patients are ... Glucagon #Baqsimi #Pharmacology